This focal point will give you an understanding of familial hypercholesterolaemia (FH), and its identification and management. It will enable you to improve care for people with known FH and identify people who are not yet diagnosed, supporting them to make informed decisions about their condition.
5h:30m (for events this includes pre and post event learning)
Learning Outcomes:
On completion of all aspects of this learning programme you should be able to:
This resource is not currently available to you, click for more information.
The aim of this e-learning programme is to provide you with a better understanding of vascular risk and the NHS health check programme.
It looks at the health policy surrounding the NHS health check programme and how it is commissioned. This learning defines cardiovascular risk and looks at some of the different assessment tools available and how these are used to estimate an individual’s cardiovascular risk.
It looks at the importance of communication with patients about their modifiable risk factors. Information on how to perform the NHS health check has been included and how to embed clinical governance into your NHS health check service.
6h:00m (for events this includes pre and post event learning)
Learning Outcomes:
On completion of this learning programme you should be able to:The aim of this e-course is to develop your knowledge and skills in cardiovascular therapeutics. This will enable you to provide a person-centred approach to support the healthcare of people living with or at higher risk of cardiovascular disease. It is designed for pharmacy professionals working in all areas of practice.
To facilitate your learning, we have structured the course into seven units. Some units are larger than others, but we estimate that you will need to commit an average of three hours of learning for each unit.
21h:00m (for events this includes pre and post event learning)
Learning Outcomes:
On completion of all aspects of this learning programme, you should be able to:
The aim of this e-learning programme is to provide learners with a basic awareness of important blood tests and how to interpret them in order to support the diagnosis and management of patients. Section 2 covers chronic disease markers including interpreting lipid profile, urea and electrolytes and liver function tests.
There are three sections which make up this learning programme. To access the other sections, select the links below:
Section 1 covers full blood count, inflammatory markers and coagulation.
Section 3 covers thyroid function tests, bone function tests and therapeutic drug monitoring.
Please note: this e-learning programme has been developed and provided by the Welsh Centre for Pharmacy Professional Education (WCPPE). Users should recognise that this programme may refer to Welsh policies and organisations. CPPE does not maintain control over the accuracy and currency of this programme.
3h:00m (for events this includes pre and post event learning)
Learning Outcomes:
On completion of all three sections of this learning programme you should be able to:Learn what the monitoring requirements, and targets associated with HbA1c and cholesterol results, are for people with type 2 diabetes, interpret those results accurately, and develop strategies to support patients in achieving their targets.
This case study forms part of the Biochemistry learning gateway. On this learning gateway page, you will find a range of learning resources which aim to increase your knowledge, skills, and confidence in relation to biochemistry.
1h:00m (for events this includes pre and post event learning)
Learning Outcomes:
On completion of all aspects of this learning programme you should be able to:
This e-assessment is linked with the CPPE Familial hypercholesterolaemia: supporting people better focal point programme and assesses you on the learning outcomes within that programme.
Why should I do this assessment?
This e-assessment completes the learning you began with the CPPE Familial hypercholesterolaemia: supporting people better focal point programme. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a revalidation record on the learning. It may also provide evidence for achieving competencies in the different competency frameworks that apply across your career.
This e-assessment is linked with the CPPE Fundamentals of cardiovascular therapeutics e-course programme, and assesses you on the learning outcomes in that programme.
Why should I do this assessment?
This e-assessment completes the learning you began with the CPPE Fundamentals of cardiovascular therapeutics e-course. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a CPD entry on the learning. It may also provide evidence for achieving competencies in the different competency frameworks that apply across your career. If you are working towards completing a Declaration of Competence for a pharmacy service, successful completion of this assessment will provide evidence of your learning.
This NICE Clinical knowledge summary (CKS) offers background information on lipid modification to reduce risk of cardiovascular disease. It also provides details on management.
This guideline covers cardiovascular risk assessment and reduction in adults without established cardiovascular disease. It covers lifestyle changes and lipid-lowering treatment, including statins, for primary and secondary prevention of cardiovascular disease. It includes guidance for people who also have diabetes or chronic kidney disease.
This guideline covers identifying and managing familial hypercholesterolaemia (FH – a specific type of high cholesterol that runs in the family) in children, young people and adults.
The Clinical Pathway Initiative resource is a process map of the clinical pathway for case-finding and testing in FH, and is being developed in partnership between the NHS Genomics Education Programme (GEP) and the Academic Health Science Network (AHSN). It details competencies, mapped educational resources and potential supporting digital solutions, and will be made available here in due course.
This document describes the consistent standards and safe environment for the use of point of care testing equipment and devices for diagnosis, monitoring and screening in community pharmacy, to guide both commissioners of NHS services and community pharmacies.
Please help us improve our website by letting us know what you like and reporting anything that isn't quite right.
